Executive order on psychedelics ignores nonmedicinal use
President Donald Trump issued an executive order aimed at accelerating medical treatments for serious mental illness by facilitating regulatory approval of psychedelics like ibogaine. The order excludes non-medicinal use of psychedelics, leaving users who don't qualify for medical exceptions as potential criminals.
President Donald Trump issued an executive order to accelerate medical treatments for serious mental illness by facilitating regulatory approval of psychedelics like ibogaine. The order aims to help individuals with conditions such as post-traumatic stress disorder (PTSD). Ibogaine has been found to provide relief from PTSD in combat veterans. A recent Nature Mental Health study found that ibogaine safely and effectively reduces PTSD, anxiety, and depression in veterans with traumatic brain injuries. However, the executive order excludes non-medicinal use of psychedelics, leaving many users who don't qualify for medical exceptions at risk of arrest and prosecution. The Food and Drug Administration has designated MDMA and psilocybin as 'breakthrough' therapies, which may soon be approved as prescription medications.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.